← SynDRA
INCA-6
SynDRA canonical compound SYN0086829 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NFATC1 |
|---|
| Mechanism of action | Calcineurin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 9,10-Dihydro-9,10[1',2']-benzenoanthracene-1,4-dione
- 9,10-Dihydro-9,10(1',2')-benzenoanthracene-1,4-dione
- RefChem:1074816
- NFAT Activation Inhibitor III
- 9,10-Dihydro-9,10[1,2]-benzenoanthracene-1,4-dione
- NSC 25996; Triptycene-1,4-quinone
- NSC25996
- Probes1_000423
- Probes2_000449
- CBDivE_014338
- INCA-?6
- SCHEMBL881196
- 9,10-o-Benzeno-9,10-dihydroanthracene-1,4-dione
- orb1704962
- SCHEMBL29454008
- CHEBI:92582
- GCHPUOHXXCNSQL-UHFFFAOYSA-N
- GLXC-21563
- HMS3268N19
- HMS3413I17
- HMS3677I17
- DAA51982
- LSM-2729
- EBC-13519
- EX-A14223
- MFCD00226933
- NSC-25996
- STK949299
- AKOS002186209
- INCA-6 NFAT Activation Inhibitor III
- NCGC00092319-01
- DA-74465
- MS-24049
- HY-108544
- CS-0029115
- ST50077427
- H40626
- T21807
- BRD-K33308633-001-01-6
Look up INCA-6 in the interactive SynDRA portal →